The genetic mutation that causes Huntington's disease (HD)—a devastating brain disease that disrupts mobility and diminishes ...
Bayer has become the latest in a long line of drug developers to give up on Huntington’s disease after the German pharma ...
A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...
The show is a joint project by artists Bert and Elise Holland, Charlotte, Clair, Evie, Kate, Spencer James and Steven Hart.
Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...
News Medical on MSN9d
New insights into early Huntington's disease mechanismsResearchers uncover a link between impaired glutathione–ascorbate metabolism and early dopamine increases in Huntington's ...
Huntington's disease is a devastating, fatal neurological illness with little means of treatment, but a new study in mice ...
Engineered polymers interfere with protein interactions to protect cell health in a mouse study. Researchers at Northwestern University and Case Western Reserve University have developed the first ...
Scientists have developed a novel polymer-based therapy that could slow Huntington's disease progression by preventing ...
News Medical on MSN10d
Researchers develop the first polymer-based therapeutic for Huntington’s diseaseBreakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...
A polymer has been developed to optimize the use of a peptide to treat Huntington’s disease in mice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback